V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008372 | 240005124 | 1.61 | 125.6 | Palliative (P) | 2013-09-23 | 2013-09-24 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | N | 240009581 | R CODOX M |
| 240008373 | 240005125 | 1.67 | 86 | Palliative (P) | null | 2016-02-22 | CISPLATIN + FLUOROURACIL | N | N | 240009587 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008374 | 240010835 | 1.74 | 71 | Palliative (P) | 2016-09-27 | 2016-09-28 | Cyclophosphamide + Dex + Rituximab | 02 | N | 240009614 | GEMCARBO |
| 240008375 | 240005126 | 1.72 | 85.4 | Disease modification (D) | null | 2015-08-22 | DA-EPOCH-R | null | N | 240009615 | CISPLATIN + PACLITAXEL |
| 240008376 | 240005126 | 1.9 | 54.3 | Palliative (P) | 2017-03-27 | 2017-03-27 | RCEOP | N | N | 240009615 | LENALIDOMIDE |
| 240008377 | 240005127 | 0 | 80.8 | Disease modification (D) | 2018-06-26 | 2018-07-02 | GALLIUM TRIAL | 02 | N | 240009658 | CISPLATIN + FLUOROURACIL |
| 240008378 | 240005128 | 1.67 | 89.8 | Curative (C) | 2016-10-27 | 2016-10-27 | Methotrexate intrathecal | 02 | N | 240009661 | DHAP - R |
| 240008379 | 240005129 | 1.69 | 63 | Curative (C) | 2017-05-08 | 2017-05-09 | Gemcitabine weekly | N | N | 240009712 | IVA |
| 240008380 | 240005130 | 1.61 | 68 | Palliative (P) | 2016-02-12 | 2016-02-12 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 240009723 | BEVACIZUMAB |
| 240008381 | 240005131 | 1.67 | 49 | Curative (C) | 2018-05-26 | 2018-06-19 | Methotrexate intrathecal | 02 | N | 240009728 | SUNITINIB |
| 240008382 | 240005132 | 1.65 | 66 | Palliative (P) | 2018-02-17 | 2018-03-04 | FLUDARABINE | N | Y | 240009734 | CYTARABINE |
| 240008383 | 240005133 | 1.63 | 67.7 | Curative (C) | 2017-09-25 | 2017-10-19 | FEC 100 | 02 | N | 240009750 | CISPLATIN + ETOPOSIDE |
| 240008384 | 240005134 | 1.73 | 80.2 | Curative (C) | 2015-12-30 | 2016-01-05 | DA-EPOCH-R | N | N | 240009785 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008385 | 240010837 | 1.68 | 94.7 | Disease modification (D) | null | 2017-06-07 | TAC | N | N | 240009819 | BEVACIZUMAB |
| 240008386 | 240010837 | 1.47 | 67.4 | Disease modification (D) | 2018-01-17 | 2018-01-18 | FLAG + Idarubicin | Y | N | 240009819 | BEVACIZUMAB |
| 240008387 | 240005135 | 1.75 | 82.9 | Palliative (P) | 2017-02-02 | 2017-02-07 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 240009826 | AML18 TRIAL |
| 240008388 | 240005135 | 1.7 | 72.8 | Adjuvant (A) | null | 2014-03-14 | Cisplatin + Etoposide (3 day) | N | N | 240009826 | CYCLO + RITUXIMAB + VINCRISTINE |
| 240008389 | 240013610 | 1.66 | 73.8 | null | 2015-02-24 | 2015-03-16 | AML18 PILOT TRIAL | N | N | 240009959 | FCR |
| 240008390 | 240005136 | 1.72 | 103 | Palliative (P) | 2017-12-21 | 2017-12-25 | ABVD | 02 | N | 240009964 | ECF |
| 240008391 | 240005136 | 1.78 | null | Palliative (P) | null | 2014-12-28 | GDP | null | null | 240009964 | GEMCARBO |
| 240008392 | 240005137 | 1.47 | null | null | 2018-07-13 | 2018-07-17 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | 02 | N | 240010015 | UKALL60+ |
| 240008393 | 240005137 | 1.43 | 53 | Curative (C) | 2016-12-05 | 2016-12-06 | CYCLO + RITUXIMAB + VINCRISTINE | N | N | 240010015 | FCR |
| 240008394 | 240005138 | 1.52 | 65.8 | null | 2017-04-09 | 2017-04-10 | CYCLOPHOSPHAMIDE + FLUDARABINE | N | N | 240010068 | DHAP |
| 240008395 | 240010841 | 1.61 | 85.4 | null | 2014-04-07 | 2014-04-14 | ESHAP R | Y | N | 240010070 | CISPLATIN + ETOPOSIDE + RT |
| 240008396 | 240005139 | 1.68 | 81.7 | Curative (C) | 2017-10-28 | 2017-10-29 | Cisplatin + Paclitaxel | Y | N | 240010103 | CHLVPP |
| 240008397 | 240005140 | 1.55 | 68.9 | Curative (C) | 2015-02-22 | 2015-02-23 | NHL 2003 Gp B COPADM 1 & 2 | N | N | 240010149 | CARBOPLATIN + PACLITAXEL + RT |
| 240008398 | 240005141 | 1.63 | 87.5 | Curative (C) | 2013-10-28 | 2013-11-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 240010160 | NORDIC |
| 240008399 | 240005142 | 1.6 | 54.5 | Palliative (P) | 2019-01-30 | 2019-02-09 | Cyclophosphamide + Dex + Rituximab | N | N | 240010188 | R CODOX M |
| 240008400 | 240005142 | null | 77 | Curative (C) | null | 2017-05-21 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | null | 240010188 | R CODOX M |
| 240008401 | 240005143 | 1.61 | null | Palliative (P) | 2015-12-12 | 2015-12-24 | CISPLATIN + FLUOROURACIL + RT | N | N | 240010237 | CISPLATIN + ETOPOSIDE |
| 240008402 | 240005144 | 1.93 | 91 | Disease modification (D) | 2016-01-11 | 2016-01-16 | AML 18 TRIAL | null | N | 240010239 | GEMCITABINE |
| 240008403 | 240010843 | 1.48 | null | Disease modification (D) | 2018-03-01 | 2018-03-01 | FEC | 2 | null | 240010283 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 240008404 | 240005145 | 1.63 | 95.9 | Palliative (P) | 2013-12-01 | 2013-12-01 | Cytarabine Low Dose | 2 | N | 240010286 | DOXORUBICIN |
| 240008405 | 240005145 | 1.56 | null | Disease modification (D) | 2016-07-03 | 2016-07-07 | CISPLATIN + FLUOROURACIL + RT | 2 | N | 240010286 | CAPECITABINE |
| 240008406 | 240013611 | 1.6 | 100.1 | Palliative (P) | 2017-07-11 | 2017-07-12 | Cyclophosphamide + Vincristine | Y | N | 240010321 | FCR |
| 240008407 | 240005146 | 1.75 | 77 | Curative (C) | null | 2015-09-01 | Cyclophosphamide + Dex + Rituximab | N | N | 240010334 | LEAM |
| 240008408 | 240010845 | 1.71 | 71 | Curative (C) | 2019-03-14 | 2019-03-20 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 240010386 | RCEOP |
| 240008409 | 240010845 | 1.76 | 63.3 | Curative (C) | null | 2019-04-02 | IBRUTINIB | 01 | N | 240010386 | CODOX M |
| 240008410 | 240010845 | 1.65 | 89 | Curative (C) | 2014-11-03 | 2014-10-27 | CHOP R + METHOTREXATE | N | N | 240010386 | ECX |
| 240008411 | 240005147 | 1.64 | 79.4 | Disease modification (D) | 2013-08-07 | 2013-08-07 | Cisplatin + Etoposide (3 day) | N | null | 240010414 | CISPLATIN + VINORELBINE |
| 240008412 | 240005148 | 1.8 | 60.9 | Curative (C) | 2014-05-23 | 2014-06-06 | GemCarbo Days 1+8 | N | N | 240010430 | CYCLOPHOSPHAMIDE |
| 240008413 | 240010846 | 1.82 | 130 | Curative (C) | 2017-04-28 | 2017-05-05 | Fludarabine oral | 02 | N | 240010434 | CHOEP |
| 240008414 | 240005149 | 1.6 | 43.4 | Not known (9) | 2017-11-19 | 2017-12-02 | ABVD | N | N | 240010441 | IVAC |
| 240008415 | 240005150 | 1.62 | 0 | Curative (C) | 2016-02-25 | 2016-03-28 | Cyclophosphamide + Dex + Rituximab | N | Y | 240010461 | CISPLATIN + FLUOROURACIL |
| 240008416 | 240010847 | 1.71 | 71 | Palliative (P) | 2018-11-11 | 2018-11-17 | WT1 TRIAL | 02 | null | 240010545 | CVP |
| 240008417 | 240010847 | 1.8 | 97.4 | Palliative (P) | 2017-07-20 | 2017-07-21 | ABVD | 02 | N | 240010545 | MPV |
| 240008418 | 240014969 | 1.69 | 64.7 | null | 2017-03-24 | 2017-03-24 | Cisplatin + Etoposide + RT | N | N | 240010563 | CISPLATIN + TOPOTECAN |
| 240008419 | 240015664 | 1.72 | 90.7 | Adjuvant (A) | 2015-01-22 | 2015-02-02 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 240010579 | CISPLATIN + GEMCITABINE |
| 240008420 | 240016016 | 1.56 | 78 | Curative (C) | 2016-09-03 | 2016-09-09 | NORDIC | N | N | 240010622 | CISPLATIN + ETOPOSIDE |
| 240008421 | 240016016 | 1.59 | 79.6 | null | 2017-07-09 | 2017-07-09 | PEMBROLIZUMAB | N | N | 240010622 | R-EPOCH |